Login
Israel-Hamas Conflict
Memorial Day
Baseball
Social Media
Premier League
Donald Trump
Cryptocurrency
Soccer
French Open
Cannes Film Festival
World Cup
Inauguration
Accident
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

PL BioScience and DewCell Plan to Jointly Develop Artificial Human Platelets for Scalable Cell Culture Media

Summary by bionity.com
PL BioScience GmbH, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with the Korean biotech company DewCell Biotherapeutics for the...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
bionity.combionity.com

PL BioScience and DewCell Plan to Jointly Develop Artificial Human Platelets for Scalable Cell Culture Media

PL BioScience GmbH, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with the Korean biotech company DewCell Biotherapeutics for the...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

bionity.com broke the news in on Wednesday, May 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Germany

Germany

News
For You
SearchBlindspotLocal